Tempus AI to buy Personalis for USD 16.25 a share in USD 1.5 billion deal
TEM•Tempus AI agrees to acquire Personalis
- Tempus AI agreed to acquire Personalis for USD 16.25 per share, valuing the deal at USD 1.5 billion net of Tempus’ existing stake.
- Consideration is all stock with a floating exchange ratio, capped at 0.3356 Tempus shares per Personalis share.
- Tempus can elect to pay up to 50% of consideration in cash, funded by cash on hand and existing credit facilities.
- Closing is expected in late 2026 or early 2027, subject to shareholder and regulatory approvals.
- Personalis reported preliminary Q2 revenue of USD 22.4 million, with 10,384 clinical tests delivered, up 33% quarter over quarter.
